LivaNova PLC (NASDAQ: LIVN) and Neogen Corporation (NASDAQ:NEOG) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitabiliy, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.


This table compares LivaNova PLC and Neogen Corporation’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LivaNova PLC -0.92% 8.77% 6.38%
Neogen Corporation 11.67% 9.64% 8.60%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for LivaNova PLC and Neogen Corporation, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova PLC 0 3 1 0 2.25
Neogen Corporation 0 2 0 0 2.00

LivaNova PLC presently has a consensus price target of $61.33, indicating a potential downside of 1.25%. Given LivaNova PLC’s stronger consensus rating and higher probable upside, equities research analysts plainly believe LivaNova PLC is more favorable than Neogen Corporation.

Earnings & Valuation

This table compares LivaNova PLC and Neogen Corporation’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
LivaNova PLC $1.21 billion 2.51 $193.82 million ($0.23) -270.04
Neogen Corporation $352.83 million 7.37 $75.97 million $1.08 63.20

LivaNova PLC has higher revenue and earnings than Neogen Corporation. LivaNova PLC is trading at a lower price-to-earnings ratio than Neogen Corporation, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

LivaNova PLC has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Neogen Corporation has a beta of 1.52, suggesting that its share price is 52% more volatile than the S&P 500.

Institutional & Insider Ownership

72.3% of LivaNova PLC shares are held by institutional investors. Comparatively, 86.4% of Neogen Corporation shares are held by institutional investors. 0.3% of LivaNova PLC shares are held by insiders. Comparatively, 4.7% of Neogen Corporation shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.


Neogen Corporation beats LivaNova PLC on 8 of the 13 factors compared between the two stocks.

About LivaNova PLC

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Cardiac Rhythm Management segment is engaged in the development, manufacturing and marketing of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Cardiac Rhythm Management products include high-voltage defibrillators Cardiac Resynchronization Therapy device (CRT-D) and low-voltage pacemakers. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.

About Neogen Corporation

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with's FREE daily email newsletter.